GLUE Monte Rosa Therapeutics Inc

held by 1 manager in Q2 2026

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.17%	3 mo	NEW	$7M	297,600

Search